| Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review CX Pan, MS Lee, VE Nambudiri Therapeutic advances in vaccines and immunotherapy 10, 25151355221084535, 2022 | 39 | 2022 |
| Charge-mediated pyrin oligomerization nucleates antiviral IFI16 sensing of herpesvirus DNA KK Lum, TR Howard, C Pan, IM Cristea MBio 10 (4), 10.1128/mbio. 01428-19, 2019 | 37 | 2019 |
| WHIM Syndrome Caused by Waldenström’s Macroglobulinemia-Associated Mutation CXCR4 L329fs Q Liu, C Pan, L Lopez, J Gao, D Velez, S Anaya-O’Brien, J Ulrick, P Littel, ... Journal of clinical immunology 36, 397-405, 2016 | 31 | 2016 |
| Transdermal approaches to vaccinations in the COVID-19 pandemic era MS Lee, CX Pan, VE Nambudiri Therapeutic Advances in Vaccines and Immunotherapy 9, 25151355211039073, 2021 | 9 | 2021 |
| Impact of ethnicity on the diagnosis and management of cutaneous toxicities from immune checkpoint inhibitors LL Thompson, CX Pan, MS Chang, NA Krasnow, AE Blum, ST Chen Journal of the American Academy of Dermatology 84 (3), 851-854, 2021 | 8 | 2021 |
| Sun-protective behaviors and skin cancer risk factors among American Indians and Alaskan Natives in the United States K Yang, CX Pan, B Kassamali, G Zhou, AH LaChance, VE Nambudiri Journal of the American Academy of Dermatology 88 (2), 488-490, 2023 | 4 | 2023 |
| Disease flare in patients with dermatomyositis following COVID-19 vaccination CX Pan, N Goldman, DY Kim, R Rowley, M Schaefer, AH LaChance, ... Journal of the American Academy of Dermatology 87 (6), 1373-1374, 2022 | 4 | 2022 |
| Recurrent reactive infectious mucocutaneous eruption: A retrospective cohort study CX Pan, SH Hussain Journal of the American Academy of Dermatology 89 (2), 361-364, 2023 | 3 | 2023 |
| A systematic review of patient-reported outcome measures for advanced skin cancer patients ME Reinhardt, T Sun, CX Pan, CD Schmults, EH Lee, AB Waldman Archives of Dermatological Research 315 (6), 1473-1480, 2023 | 3 | 2023 |
| Mepolizumab for refractory eosinophilic fasciitis: a retrospective analysis from two tertiary care centres. SN Sanchez-Melendez, KS Shaw, CX Pan, DL Taylor, N Shahriari, ... Clinical and Experimental Rheumatology, 2023 | 3 | 2023 |
| Nonmelanoma skin cancer in patients with hereditary hemochromatosis: A case-control study CX Pan, K Yang, CB Lau, G Zhou, VE Nambudiri Journal of the American Academy of Dermatology 88 (3), 692-694, 2023 | 3 | 2023 |
| International medical graduate dermatologists in rural and medically underserved areas: a national cross-sectional analysis CX Pan, VE Nambudiri Archives of Dermatological Research 314 (8), 799-803, 2022 | 2 | 2022 |
| A 72-year-old man with nonhealing facial erosions and bullae CX Pan, CE Pisano, MS DeSimone, VE Nambudiri JAAD Case Reports 27, 99-102, 2022 | 2 | 2022 |
| Assessment of the representation of black, indigenous and people of colour in dermatology clinical practice guidelines CX Pan, K Yang, VE Nambudiri British Journal of Dermatology 187 (3), 443-445, 2022 | 2 | 2022 |
| Association between baseline lactate dehydrogenase and immune-related adverse events among patients with melanoma varies by tumor stage at immune checkpoint inhibitor initiation CX Pan, WC Lau, DY Kim, CB Lau, R Rowley, R Kanwar, NR LeBoeuf, ... Journal of the American Academy of Dermatology 89 (6), 1264-1268, 2023 | 1 | 2023 |
| Novel Cancer Treatment Using Oncolytic Virus Therapy CX Pan, DY Kim, VE Nambudiri Handbook of Cancer and Immunology, 1-43, 2022 | 1 | 2022 |
| Characterization of intravascular papillary endothelial hyperplasia: a multicentre cohort K Yang, CX Pan, EE Russell‐Goldman, VE Nambudiri Clinical and Experimental Dermatology 47 (8), 1550-1553, 2022 | 1 | 2022 |
| Histopathological predictors of immune-related adverse events among patients with melanoma treated with immune checkpoint inhibitors CX Pan, M Liu, CB Lau, WC Lau, DY Kim, SA Saberi, R Rowley, ... Journal of the American Academy of Dermatology 90 (4), 826-829, 2024 | | 2024 |
| Comparative analysis of immune-related adverse events among patients with melanoma on immune checkpoint inhibitors: a retrospective cohort study CX Pan, DY Kim, CB Lau, WC Lau, R Rowley, R Kanwar, NR LeBoeuf, ... British Journal of Dermatology 189 (5), 637-640, 2023 | | 2023 |
| Clinicopathologic features of ecthyma gangrenosum: a single integrated health system cohort WC Lau, K Yang, CB Lau, CX Pan, B Kassamali, VE Nambudiri Archives of Dermatological Research 315 (9), 2717-2719, 2023 | | 2023 |
